Advertisement

Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene

  1. Konstantinos Kantartzis1,
  2. Andreas Peter1,
  3. Fausto Machicao1,
  4. Jürgen Machann2,
  5. Silvia Wagner3,
  6. Ingmar Königsrainer3,
  7. Alfred Königsrainer3,
  8. Fritz Schick2,
  9. Andreas Fritsche1,
  10. Hans-Ulrich Häring1 and
  11. Norbert Stefan1
  1. 1Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Medicine, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany;
  2. 2Section on Experimental Radiology, University of Tübingen, Tübingen, Germany;
  3. 3Department of General, Visceral and Transplant Surgery, University of Tübingen, Tübingen, Germany.
  1. Corresponding author: N. Stefan, norbert.stefan{at}med.uni-tuebingen.de.

Abstract

OBJECTIVE In a genome-wide association scan, the rs738409 C>G single nucleotide polymorphism (SNP) in the patatin-like phospholipase 3 gene (PNPLA3) was strongly associated with increased liver fat but not with insulin resistance estimated from fasting values. We investigated whether the SNP determines liver fat independently of visceral adiposity and whether it may even play a role in protecting from insulin resistance.

RESEARCH DESIGN AND METHODS Liver fat was measured by 1H magnetic resonance spectroscopy and total and visceral fat by magnetic resonance tomography in 330 subjects. Insulin sensitivity was estimated during an oral glucose tolerance test and the euglycemic-hyperinsulinemic clamp (n = 222). PNPLA3 and tumor necrosis factor-α mRNA and triglyceride content were measured in liver biopsies from 16 subjects.

RESULTS Liver fat correlated strongly with insulin sensitivity (P < 0.0001) independently of age, sex, total fat, and visceral fat. G allele carriers of the SNP rs738409 had higher liver fat (P < 0.0001) and an odds ratio of 2.38 (95% CI 1.37–4.20) for having fatty liver compared to C allele homozygotes. Interestingly, insulin sensitivity (oral glucose tolerance test: P = 0.99; clamp: P = 0.32), serum C-reactive protein levels, lipids, or liver enzymes (all P > 0.14) were not different among the genotypes. Additional adjustment for liver fat actually revealed increased insulin sensitivity in more obese carriers of the G allele (P = 0.01). In liver biopsies triglyceride content correlated positively with expression of the proinflammatory gene tumor necrosis factor-α in C allele homozygotes (n = 6, P = 0.027) but not in G allele carriers (n = 10, P = 0.149).

CONCLUSIONS PNPLA3 may be an important key to understand the mechanisms discriminating fatty liver with and without metabolic consequences.

Footnotes

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • Received February 24, 2009.
    • Accepted July 17, 2009.
| Table of Contents

This Article

  1. Diabetes November 2009 vol. 58 no. 11 2616-2623
  1. » Abstract
  2. All Versions of this Article:
    1. db09-0279v1
    2. 58/11/2616 most recent

Social Bookmarking

Advertisement